Chromocure, Inc. (GM CE) Stock Price - KKUR

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Chromocure, Inc. (GM CE) KKUR Other OTC Common Stock Ordinary Shares
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.00% 0.000001 0.00 0.00 0.00 0.000001 20:00:00
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00 USD

Chromocure, Inc. (GM CE) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 8.2k 8.2B - - 2.15B
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Chromocure, Inc. (GM CE) News

Latest KKUR Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical KKUR Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.0000010.0000010.0000010.000014k14k14k0-
1 Month0.0000010.0000010.0000010.0000614k5k0-
3 Months0.0000010.000010.0000010.0000670M7M0-
6 Months0.0000010.00010.0000010.0000670M6M0-
1 Year0.0000010.00010.0000010.0000470M4M0-
3 Years0.000010.0010.0000010.0000470M3M-0.000009-90.00%
5 Years0.00010.0010.0000010.0000470M3M-0.000099-99.00%

Chromocure, Inc. (GM CE) Description

ChromoCure develops and provides proprietary cancer detection systems and related therapeutic technologies. The Company's proprietary CS200 Chromosomal Scanner has been proven accurate and efficient in the measurement of the unique genomic characteristic found in 100% of all cancers and never found in normal cells. The Company's detection technology has an effective accuracy of 100% for all cancers at all stages. The Company believes its technology will become the worldwide gold standard for cancer detection, progression measurement, and research for both therapy and cure. The Company also applies its technology and knowledge to cancer cure and therapeutics research.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.